PUNE, India, January 27, 2023 (GLOBE NEWSWIRE) — The global Point-of-care diagnostics market The size was estimated at $46.65 billion in 2021. It is estimated to grow from US$36.37 billion in 2022 to US$51.94 billion in 2029 at a CAGR of 5.2% over the forecast period. Fortune Business Insights™ published this information in its latest research report titled, Point of Care Diagnostics Market Forecast, 2022-2029. The Point-of-Care Diagnostics Market report provides complete information on the recent developments and trends in the industry. Also, this report further highlights development strategies of major market players such as mergers, acquisitions, alliances, and partnerships.

Key Industry Development:

Celltrion Group announced the SARS-CoV-2 Point-of-Care Antigen Diagnostic Kit. This will help expand access to COVID-19 diagnostic management and treatment worldwide.

Thermo Fisher Scientific and Color Health have partnered to bring a k-12 readycheckgo Covid-19 testing solution to Texas schools.

Request a Sample Global Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/point-of-care-diagnostics-market-101072

Report scope and segmentation

The central theses:

• Patient demand for diagnostic products is expected to increase in the coming years driving the growth in the POC diagnostics market.
• New technologies to manufacture POC test kits are expected to drive the global market growth during the forecast period.
• The high prevalence of the diseases is a major driver of the demand for POC diagnostics during the forecast period.
• North America had a revenue of US$14.48 billion in 2021 and is expected to dominate the market during the forecast period.

Market leader: